Cordis is a prominent global medical device company with a long and influential history in the development and manufacturing of technologies for treating vascular disease. While it operates globally, its presence in the USA is significant, with major operations in Miami Lakes, Florida, and the San Francisco Bay Area. For decades, Cordis has been a pioneering force in interventional cardiology and endovascular medicine, providing physicians with the tools needed to perform minimally invasive procedures that diagnose and treat diseases of the arteries and veins.
The company has a complex ownership history, having been a part of Johnson & Johnson for many years before being sold to Cardinal Health in 2015, and subsequently acquired by the private equity firm Hellman & Friedman in 2021. This most recent change has repositioned Cordis as a standalone company, focused on reinvigorating its legacy of innovation and expanding its portfolio in the cardiovascular space.
Core Business: Interventional Vascular Technology
Cordis's core business is centered on providing a comprehensive suite of products for minimally invasive, image-guided procedures used to treat patients with vascular conditions. These conditions include coronary artery disease (blockages in the heart's arteries), peripheral artery disease (blockages in the arteries of the legs, arms, and other parts of the body), and aneurysms. The company's products are used by interventional cardiologists, interventional radiologists, and vascular surgeons to open blocked vessels, restore blood flow, and repair vascular damage.
The product portfolio is generally categorized into two main areas: Cardiology (focusing on the heart) and Endovascular (focusing on peripheral vessels and other non-cardiac vasculature).
Key Products and Services
Cordis offers a wide array of products that cover the entire procedural workflow, from accessing the vascular system to treating the lesion and closing the access site.
1. Cardiology Products
These products are used primarily for percutaneous coronary intervention (PCI), a non-surgical procedure used to treat narrowed coronary arteries.
Access Products:
Guiding Catheters: These specialized catheters, such as the VISTA BRITE TIP?, provide a stable pathway for other devices to reach the coronary arteries.
Sheath Introducers: The AVANTI?+ sheath is used to create a secure port of entry into an artery (typically the radial or femoral artery).
Diagnostic and Interventional Catheters:
Angiographic Catheters: Used with contrast media to visualize the coronary arteries and identify blockages.
PTCA Balloons:EMERGE? and SABER? percutaneous transluminal coronary angioplasty (PTCA) balloon catheters are used to pre-dilate a lesion before stenting or as a standalone treatment to open a blocked artery.
Coronary Stents: While Cordis was a pioneer in coronary stenting, its portfolio has evolved. It continues to provide foundational bare-metal stent technology in certain markets, though its focus has shifted more towards other areas of the interventional toolkit.
2. Endovascular Products
Cordis has a very strong and comprehensive portfolio for treating peripheral artery disease (PAD) and other non-coronary vascular conditions.
Peripheral Stents:
S.M.A.R.T.? Stent: This is one of Cordis's most well-known and successful products. The S.M.A.R.T.? is a self-expanding nitinol stent renowned for its excellent durability, flexibility, and long-term clinical data, particularly for treating lesions in the superficial femoral artery (SFA) in the leg.
PALMAZ? GENESIS? Stent: A balloon-expandable stent often used for treating lesions in the iliac arteries.
Peripheral Angioplasty Balloons:
SABERX? and AVIATOR? Plus: These are percutaneous transluminal angioplasty (PTA) balloons designed for the varied anatomy and lesion types found in peripheral arteries.
CHOCOLATE? PTA Balloon Catheter: A unique "caged" balloon design that minimizes trauma to the vessel wall during inflation, intended to reduce the rate of dissections.
Atherectomy Systems:
VERSACUTT? Atherectomy System: A rotational atherectomy device used to debulk and remove plaque from arterial walls.
Endovascular Aneurysm Repair (EVAR):
INCRAFT? AAA Stent-Graft System: A low-profile device used for the minimally invasive repair of abdominal aortic aneurysms (AAAs). Its ultra-low profile design allows it to be used in patients with smaller access vessels.
Vena Cava Filters:
OPTEASE? and TRAPEASE?: These are filters implanted in the vena cava to capture blood clots before they can travel to the lungs and cause a pulmonary embolism.
Chronic Venous Insufficiency (CVI) and Venous Obstruction:
INARI Medical Products: Through strategic distribution partnerships, Cordis also markets and sells products from companies like INARI Medical, which specializes in tools for treating venous thromboembolism (VTE).
3. Vascular Closure Devices
After a procedure is complete, the access site in the artery must be closed. Cordis provides market-leading devices for this purpose.
MYNXGRIP? and MYNXACE?: Vascular closure devices that use an extravascular sealant to close the access site, which can reduce time to hemostasis and improve patient comfort compared to manual compression.
EXOSEAL?: Another vascular closure device that uses a different plug-based mechanism.
Through its extensive product lines, Cordis equips physicians with a complete toolkit to manage patients with vascular disease from diagnosis to treatment and closure.
Please note: This information is generated by AI. For legal use, verify with company sources.
